IMMUNE ASPECTS OF CANCER DEVELOPMENT

Cover Page


Cite item

Full Text

Abstract

Local and systemic immune responses are involved in the development of the malignant tumor at all stages of the process, from the appearance of transformed cellsto the clinical progression of the disease. The review includes the main provision of the modern concepts of oncogenesis, antitumor immune surveillance, immunoediting and the role of tumor-promoting chronic infl ammation.

About the authors

T. A. Karmakova

P. A. Hertsen Moscow Oncology Research Institute – the branch of National Medical Research Radiological Center

Author for correspondence.
Email: kalmar123@yandex.ru

PhD, Leading Researcher, Department of Modifi ers and Protective Agents for Anticancer therapy,

Moscow

Russian Federation

References

  1. Hanahan D., Weinberg R. A. Hallmarks of cancer: the next generation. Cell. 2011, 144(5), 646–674.
  2. Gonzalez H., Hagerling C., Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018, 32, 1267–1284.
  3. Mittal D., Gubin M. M., Schreiber R. D., Smyth M. J. New insights into cancer immunoediting and its three component phases – elimination, equilibrium and escape. Curr Opin Immunol. 2014, 27, 16–25.
  4. Bottazzi B., Riboli E., Mantovani A. Aging, inflammation and cancer. SeminImmunol. 2018, 40, 74–82.
  5. D’Errico G., Machado H. L., Sainz B. Jr. A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet. Clin Trans Med. 2017, 6, 3
  6. Li Z., Song W., Rubinstein M., Liu D. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018, 11, 142.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Karmakova T.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.